Literature DB >> 35654917

Amiodarone-induced cutaneous leukocytoclastic vasculitis: a case report and a review of the literature.

Tumay Ak1, Rumeysa Nur Algan2, Senay Agirgol2, Seyhan Ozakkayunlu Hascicek3, Zafer Turkoglu2.   

Abstract

Amiodarone can be used in a variety of arrhythmias. Given its widespread use, the probability of clinicians encountering its cutaneous adverse effects is high. A few cases of amiodarone-induced cutaneous vasculitis were reported in the literature, probably because it is underdiagnosed in clinical practice. Indeed, amiodarone-related cutaneous reactions may present a wide range of manifestations and are sometimes difficult to diagnose. Herein, we report a case with a sizeable necrotic ulcer on the left lower leg shortly after amiodarone exposure. A rigorous diagnostic study was performed before concluding the diagnosis of amiodarone-induced cutaneous vasculitis, which showed the histopathological features of leukocytoclastic vasculitis. The lesion was almost completely healed by the third month of discontinuation of amiodarone. We did a literature search and found seven cases which were reported as leukocytoclastic or lymphocytic vasculitis. We reviewed previous cases and presented our case in comparison to prior cases.
© 2022. The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR).

Entities:  

Keywords:  Adverse effects; Amiodarone; Leukocytoclastic vasculitis; Skin ulcer

Mesh:

Substances:

Year:  2022        PMID: 35654917     DOI: 10.1007/s10067-022-06231-x

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   3.650


  24 in total

1.  A case report: Multaq-induced leukocytoclastic vasculitis.

Authors:  Suzanne M Smith; Mohammed Al-Bataineh; Stephen B Iorfido; Jarrod Macfarlane
Journal:  Am J Ther       Date:  2014 May-Jun       Impact factor: 2.688

2.  [Amiodarone-induced immune complex cutaneous vasculitis].

Authors:  M Ndiaye; B Lebrun-Vignes; N Ortonne; L Fardet
Journal:  Ann Dermatol Venereol       Date:  2017-09-19       Impact factor: 0.777

3.  Adverse effects of low dose amiodarone: a meta-analysis.

Authors:  V R Vorperian; T C Havighurst; S Miller; C T January
Journal:  J Am Coll Cardiol       Date:  1997-09       Impact factor: 24.094

Review 4.  The role of intravenous amiodarone in the management of cardiac arrhythmias.

Authors:  A D Desai; S Chun; R J Sung
Journal:  Ann Intern Med       Date:  1997-08-15       Impact factor: 25.391

5.  Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy.

Authors:  E Martino; M Safran; F Aghini-Lombardi; R Rajatanavin; M Lenziardi; M Fay; A Pacchiarotti; N Aronin; E Macchia; C Haffajee
Journal:  Ann Intern Med       Date:  1984-07       Impact factor: 25.391

Review 6.  Amiodarone pulmonary toxicity. Recognition and pathogenesis (Part I).

Authors:  W J Martin; E C Rosenow
Journal:  Chest       Date:  1988-05       Impact factor: 9.410

7.  Fatal hepatotoxicity following oral administration of amiodarone.

Authors:  M Richer; S Robert
Journal:  Ann Pharmacother       Date:  1995-06       Impact factor: 3.154

Review 8.  Amiodarone-induced vasculitis and a review of the cutaneous side-effects of amiodarone.

Authors:  G Dootson; C Byatt
Journal:  Clin Exp Dermatol       Date:  1994-09       Impact factor: 3.470

Review 9.  Amiodarone-associated proarrhythmic effects. A review with special reference to torsade de pointes tachycardia.

Authors:  S H Hohnloser; T Klingenheben; B N Singh
Journal:  Ann Intern Med       Date:  1994-10-01       Impact factor: 25.391

Review 10.  Cutaneous adverse reactions of amiodarone.

Authors:  Krzysztof Jaworski; Irena Walecka; Lidia Rudnicka; Maciej Gnatowski; Dariusz A Kosior
Journal:  Med Sci Monit       Date:  2014-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.